FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Pharmacology, Toxicology and Pharmaceutical Science